Faecal immunochemical test: challenges and opportunities for cancer diagnosis in primary care.
作者信息
Craig Mary, Turner Jeff, Torkington Jared, Crosby Tom
机构信息
Wales Cancer Network, Cardiff; GP Cancer Lead, Aneurin Bevan University Health Board, Newport.
Wales Cancer Network; Consultant Gastroenterologist, University Hospital Llandough, Cardiff.
出版信息
Br J Gen Pract. 2022 Jul 28;72(721):366-367. doi: 10.3399/bjgp22X720209. Print 2022 Aug.
Abstract
摘要
相似文献
1
Faecal immunochemical test: challenges and opportunities for cancer diagnosis in primary care.粪便免疫化学检测：基层医疗中癌症诊断面临的挑战与机遇
Br J Gen Pract. 2022 Jul 28;72(721):366-367. doi: 10.3399/bjgp22X720209. Print 2022 Aug.
2
Guidance on faecal immunochemical testing (FIT) to help diagnose colorectal cancer among symptomatic patients in primary care.粪便免疫化学检测（FIT）指南，以帮助在初级保健中对有症状患者进行结直肠癌诊断。
Br J Gen Pract. 2023 May 25;73(731):283-285. doi: 10.3399/bjgp23X733173. Print 2023 Jun.
3
Faecal haemoglobin examinations have come of age, but further maturation seems desirable.粪便血红蛋白检测已经成熟，但进一步完善似乎是必要的。
Ann Clin Biochem. 2022 Mar;59(2):97-100. doi: 10.1177/00045632211063459. Epub 2022 Jan 21.
4
BSG guidelines on faecal immunochemical testing: are they 'FIT' for purpose?英国胃肠病学会粪便免疫化学检测指南：它们是否“适用于”该目的？
Gut. 2023 Oct;72(10):1805-1806. doi: 10.1136/gutjnl-2022-328201. Epub 2022 Sep 16.
5
Is the quantitative faecal immunochemical test (qFIT) ready for prime time in the US?定量粪便免疫化学检测（qFIT）在美国是否已准备好广泛应用？
Colorectal Dis. 2022 May;24(5):558-561. doi: 10.1111/codi.16156. Epub 2022 May 4.
6
Comment on: Double faecal immunochemical testing in patients with symptoms suspicious of colorectal cancer.对《疑似结直肠癌患者的双重粪便免疫化学检测》的评论
Br J Surg. 2023 Jun 12;110(7):872. doi: 10.1093/bjs/znad122.
7
[Colorectal cancer screening: a work in progress].[结直肠癌筛查：一项正在进行的工作]
Presse Med. 2014 Nov;43(11):1165-7. doi: 10.1016/j.lpm.2014.08.004. Epub 2014 Sep 26.
8
Are hemoglobin levels really lower in faecal immunochemical test positive patients with colorectal cancer?粪便免疫化学检测呈阳性的结直肠癌患者的血红蛋白水平真的更低吗？
Surgeon. 2018 Feb;16(1):36-39. doi: 10.1016/j.surge.2016.12.001. Epub 2017 Jan 17.
9
[A double immunochemical method for detecting faecal haemoglobin and albumin in rectal screening].[一种用于直肠筛查中检测粪便血红蛋白和白蛋白的双重免疫化学方法]
Magy Onkol. 2011 Nov;55(4):268-73. Epub 2011 Aug 25.
10
Home-use faecal immunochemical testing: primary care diagnostic technology update.家用粪便免疫化学检测：基层医疗诊断技术更新
Br J Gen Pract. 2015 Mar;65(632):156-8. doi: 10.3399/bjgp15X684229.
引用本文的文献
1
Practitioner perspectives on symptomatic faecal immunochemical testing in the UK: a qualitative interview study.英国从业者对有症状粪便免疫化学检测的看法：一项定性访谈研究
Br J Gen Pract. 2025 May 6;75(755):e390-6. doi: 10.3399/BJGP.2024.0358.
2
Who are the patients being offered the faecal immunochemical test in routine English general practice, and for what symptoms? A prospective descriptive study.在常规英国家庭医疗实践中，哪些患者接受粪便免疫化学检测，针对哪些症状？一项前瞻性描述性研究。
BMJ Open. 2022 Sep 19;12(9):e066051. doi: 10.1136/bmjopen-2022-066051.
本文引用的文献
1
Faecal immunochemical testing (FIT) in patients with signs or symptoms of suspected colorectal cancer (CRC): a joint guideline from the Association of Coloproctology of Great Britain and Ireland (ACPGBI) and the British Society of Gastroenterology (BSG).疑似结直肠癌（CRC）体征或症状患者的粪便免疫化学检测（FIT）：英国和爱尔兰结直肠外科学会（ACPGBI）与英国胃肠病学会（BSG）联合指南
Gut. 2022 Jul 12;71(10):1939-62. doi: 10.1136/gutjnl-2022-327985.
2
Faecal immunochemical test to triage patients with possible colorectal cancer symptoms: meta-analysis.粪便免疫化学试验对疑似结直肠癌症状患者的分诊：荟萃分析。
Br J Surg. 2022 Feb 1;109(2):182-190. doi: 10.1093/bjs/znab411.
3
Recognising Colorectal Cancer in Primary Care.在初级保健中识别结直肠癌。
Adv Ther. 2021 May;38(5):2732-2746. doi: 10.1007/s12325-021-01726-6. Epub 2021 Apr 17.
4
Using the faecal immunochemical test in patients with rectal bleeding: evidence from the NICE FIT study.在有直肠出血症状的患者中使用粪便免疫化学检测：来自 NICE FIT 研究的证据。
Colorectal Dis. 2021 Jul;23(7):1630-1638. doi: 10.1111/codi.15593. Epub 2021 Mar 15.
5
Faecal immunochemical test is superior to symptoms in predicting pathology in patients with suspected colorectal cancer symptoms referred on a 2WW pathway: a diagnostic accuracy study.粪便免疫化学试验在预测疑似结直肠癌症状患者的病理方面优于症状，这些患者通过 2WW 途径转诊：一项诊断准确性研究。
Gut. 2021 Jun;70(6):1130-1138. doi: 10.1136/gutjnl-2020-321956. Epub 2020 Oct 21.
6
Prioritisation by FIT to mitigate the impact of delays in the 2-week wait colorectal cancer referral pathway during the COVID-19 pandemic: a UK modelling study.在 COVID-19 大流行期间，通过 FIT 优先排序减轻 2 周等待期结直肠癌转诊途径延误的影响：一项英国建模研究。
Gut. 2021 Jun;70(6):1053-1060. doi: 10.1136/gutjnl-2020-321650. Epub 2020 Aug 27.
7
Delays in referral from primary care worsen survival for patients with colorectal cancer: a retrospective cohort study.初级保健转诊延误使结直肠癌患者的生存恶化：一项回顾性队列研究。
Br J Gen Pract. 2020 Jun 25;70(696):e463-e471. doi: 10.3399/bjgp20X710441. Print 2020 Jul.
8
Impact of colorectal cancer screening on cancer-specific mortality in Europe: A systematic review.结直肠癌筛查对欧洲癌症特异性死亡率的影响：系统评价。
Eur J Cancer. 2020 Mar;127:224-235. doi: 10.1016/j.ejca.2019.12.014. Epub 2020 Jan 10.
9
Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study.1995-2014 年七个高收入国家癌症存活率、死亡率和发病率的进展（ICBP SURVMARK-2）：一项基于人群的研究。
Lancet Oncol. 2019 Nov;20(11):1493-1505. doi: 10.1016/S1470-2045(19)30456-5. Epub 2019 Sep 11.
10
Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years.过去 25 年欧洲年轻人结直肠癌发病率不断上升。
Gut. 2019 Oct;68(10):1820-1826. doi: 10.1136/gutjnl-2018-317592. Epub 2019 May 16.
Zotero 插件